"38-Year-Old French Woman Dies of Thrombosis After AZ Vaccination"

[Image source=Reuters Yonhap News]

[Asia Economy Reporter Cho Hyun-ui] A case of death due to blood clots after receiving the AstraZeneca COVID-19 vaccine has occurred in France.

France Info Radio reported on the 30th (local time), citing hospital sources, that "a 38-year-old woman in Toulouse died two weeks after receiving the AstraZeneca vaccine."

The woman, who had no underlying illnesses, was vaccinated with the AstraZeneca vaccine in mid-month, developed symptoms of blood clots, was hospitalized, and passed away the day before yesterday.

The causal relationship between the cause of death and the AstraZeneca vaccine administration has not been confirmed. The Agence Nationale de S?curit? du M?dicament et des Produits de Sant? (ANSM) will investigate the case.

Earlier, the Haute Autorit? de Sant? (HAS) resumed AstraZeneca vaccinations on the 19th after a temporary suspension due to concerns over blood clot side effects, recommending administration only to those aged 55 and older.

Reports of blood clots after AstraZeneca vaccination in Europe have all been from individuals under 55 years old, and it was explained that these are "very rare but serious cases."

The deceased woman was a social worker who received the AstraZeneca vaccine before the health authorities issued this recommendation.

Previously, some European countries reported blood clot formation after receiving the vaccine developed by AstraZeneca and the University of Oxford in the UK.

The European Medicines Agency (EMA) stated that after additional review, the AstraZeneca vaccine is safe and effective and maintained its approval recommendation. However, regarding the blood clot cases, it said that a clear exclusion of relatedness is not possible and further analysis is needed.

This content was produced with the assistance of AI translation services.